At a glance
ClinicalIndex Comparison RecordN/ACompleted· 1,304 enrolled
Drug / intervention
Vonoprazandrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Special Drug Use Surveillance of Takecab Tablets for "Prevention of Recurrence of Gastric/Duodenal Ulcer in Patients Receiving Non-steroidal Anti-inflammatory Drugs: Long-term Use"
In Brief
An observational study evaluating Vonoprazan for A History of Gastric or Duodenal Ulcers. Completed, enrolled 1,304 participants across 1 site.
Detailed Summary
The purpose of this study is to investigate the safety and efficacy of long-term administration of Vonoprazan tablets (Takecab tablets) for up to 12 months in the routine clinical setting in patients receiving non-steroidal anti-inflammatory drugs (NSAIDs).
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsA History of Gastric or Duodenal Ulcers
CountriesJapan
Collaborators--
Timeline
N/ACompletedFinished
2017201820192020202120222023202420252026
Enrollment StartSep 2016
First PostedJul 2017
Primary CompletionApr 2020
TodayJul 2026
First PostedJul 11, 2017
Enrollment StartSep 1, 2016
Primary CompletionApr 30, 2020
TodayJul 2, 2026
Enrollment to primary: 3.7 yearsPosted 9.0 years ago
Interventions
Vonoprazandrug
Vonoprazan tablets